Bender Robert & Associates Astrazeneca PLC Transaction History
Bender Robert & Associates
- $471 Million
- Q3 2024
A detailed history of Bender Robert & Associates transactions in Astrazeneca PLC stock. As of the latest transaction made, Bender Robert & Associates holds 13,882 shares of AZN stock, worth $921,209. This represents 0.23% of its overall portfolio holdings.
Number of Shares
13,882
Previous 16,875
17.74%
Holding current value
$921,209
Previous $1.32 Million
17.86%
% of portfolio
0.23%
Previous 0.29%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.28 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...